VpS algorithm in EVIA and ENTOVIS pacemakers
DeviceFor one group of patients, the VpS algorithm will be activated and for the other group, the VpS algorithm will be deactivated until the cross-over, where these conditions will be switched.
NCT Number: NCT01053832
Investigation of the efficacy and safety of the Ventricular Pace Suppression (VpS) algorithm.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Klinikum Coburg gGmbH, Coburg, Bavaria, Germany
The aim of this study is to investigate the percentage of reduction of ventricular pacing using the VpS feature of the EVIA/ENTOVIS pacemaker in a controlled clinical investigation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
For one group of patients, the VpS algorithm will be activated and for the other group, the VpS algorithm will be deactivated until the cross-over, where these conditions will be switched.
Time frame: 6-8 months
Time frame: 6-8 months
Biotronik SE & Co. KG
Industry
Ventricular Pace Suppression Study With the EVIA/ENTOVIS DR-T/DR Pacemaker
Acronym: VpS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00916344
Pacemaker Indication
Pessac, Bordeaux, France
View Trial Details